Jeffrey G. Lamothe Aptevo Therapeutics Inc. (APVO) insider trading activity

Jeffrey G. Lamothe is EVP, COO of Aptevo Therapeutics Inc.. Currently has a direct ownership of 1,166 shares of APVO, which is worth approximately $361. The most recent transaction as insider was on Aug 08, 2024, when has been sold 314 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.17K

0% 3M change

95.6% 12M change

Total Value Held $361

Jeffrey G. Lamothe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2024	BUY Exercise of conversion of derivative security	-	314 Added 21.22%	1,166 Common Stock
Mar 03 2024	BUY Exercise of conversion of derivative security	-	3,667 Added 8.91%	37,504 Common Stock
Mar 02 2024	BUY Exercise of conversion of derivative security	-	5,500 Added 13.98%	33,837 Common Stock
Jan 28 2024	BUY Exercise of conversion of derivative security	-	1,833 Added 6.08%	28,337 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	-	13,812 Added 34.26%	26,504 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	3,666 Added 22.41%	12,692 Common Stock
Jan 29 2023	BUY Exercise of conversion of derivative security	-	1,834 Added 16.89%	9,026 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	1,833 Added 20.31%	7,192 Common Stock

JGL

Jeffrey G. Lamothe

EVP, COO

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APVO shares.

Notify only if

Value

Insider Trading

Get notified when an Aptevo Therapeutics Inc. insider buys or sells APVO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aptevo Therapeutics Inc.

Track Activities on APVO

Account